These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28214469)

  • 1. Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.
    Ditkowsky J; Shah KH; Hammerschlag MR; Kohlhoff S; Smith-Norowitz TA
    BMC Infect Dis; 2017 Feb; 17(1):155. PubMed ID: 28214469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.
    Rours GI; Smith-Norowitz TA; Ditkowsky J; Hammerschlag MR; Verkooyen RP; de Groot R; Verbrugh HA; Postma MJ
    Pathog Glob Health; 2016; 110(7-8):292-302. PubMed ID: 27958189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Chlamydia trachomatis infection in pregnant women in Martinique.
    Chout RT; Vaton S; Duval-Violton D; Leguyader-Despres P; Orfila J
    Sex Transm Dis; 1995; 22(4):221-7. PubMed ID: 7482104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Jager HC; Coutinho RA
    Value Health; 2001; 4(3):266-75. PubMed ID: 11705188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals.
    Cabeza J; García PJ; Segura E; García P; Escudero F; La Rosa S; León S; Klausner JD
    Sex Transm Infect; 2015 Feb; 91(1):7-10. PubMed ID: 25107711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and acceptability of Chlamydia trachomatis screening among pregnant women and their partners; a cross-sectional study.
    Pereboom MT; Spelten ER; Manniën J; Rours GI; Morré SA; Schellevis FG; Hutton EK
    BMC Public Health; 2014 Jul; 14():704. PubMed ID: 25011479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae and repeat infection among pregnant urban adolescents.
    Berggren EK; Patchen L
    Sex Transm Dis; 2011 Mar; 38(3):172-4. PubMed ID: 20938375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.
    Nyári T; Nyári C; Woodward M; Mészáros G; Deák J; Nagy E; Kovács L
    Acta Obstet Gynecol Scand; 2001 Apr; 80(4):300-6. PubMed ID: 11264602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.
    Op de Coul ELM; Peek D; van Weert YWM; Morré SA; Rours I; Hukkelhoven C; de Jonge A; van Benthem B; Pereboom M
    Reprod Health; 2021 Jun; 18(1):132. PubMed ID: 34174905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia screening for pregnant women aged 16-25 years attending an antenatal service: a cost-effectiveness study.
    Ong JJ; Chen M; Hocking J; Fairley CK; Carter R; Bulfone L; Hsueh A
    BJOG; 2016 Jun; 123(7):1194-202. PubMed ID: 26307516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating Chlamydia trachomatis and Neisseria gonorrhoeae screening and treatment among asymptomatic pregnant women to prevent preterm birth and low birthweight in Gaborone, Botswana: A secondary analysis from a non-randomised, cluster-controlled trial.
    Wynn A; Mussa A; Ryan R; Babalola CM; Hansman E; Ramontshonyana K; Tamuthiba L; Ndlovu N; Wilson ML; Ramogola-Masire D; Klausner JD; Morroni C
    BJOG; 2024 Aug; 131(9):1259-1269. PubMed ID: 38351649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis infection in a sample of northern Brazilian pregnant women: prevalence and prenatal importance.
    Borborema-Alfaia AP; Freitas NS; Astolfi Filho S; Borborema-Santos CM
    Braz J Infect Dis; 2013; 17(5):545-50. PubMed ID: 23831212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
    Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
    Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should all sexually active young women in Hungary be screened for Chlamydia trachomatis?
    Nyári T; Woodward M; Kovács L
    Eur J Obstet Gynecol Reprod Biol; 2003 Jan; 106(1):55-9. PubMed ID: 12475582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
    Howell MR; Quinn TC; Gaydos CA
    Ann Intern Med; 1998 Feb; 128(4):277-84. PubMed ID: 9471930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.